Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

New distribution agreement with Nutrien

23 May 2022 07:00

RNS Number : 3452M
Plant Health Care PLC
23 May 2022
 

RNS

23 May, 2022

 

 

Plant Health Care plc

("Plant Health Care" or the "Company")

 

Long-term commercial agreement signed with Nutrien Ag Solutions for PHC's Saori® soybean seed treatment

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, announces its partnership with Nutrien Soluções Agrícolas ("Nutrien") for its Saori® soybean seed treatment is progressing ahead of expectations in Brazil.

 

Highlights

 

· PHC and Nutrien have now signed a five-year commercial agreement under which Plant Health Care will supply Saori for Nutrien's use on soybeans in Brazil.

· Saori was launched by Nutrien in September 2021; grower response has been very positive.

· PHC's revenue from sales of Saori to Nutrien is expected to exceed US$750k in the first half of 2022, growing to more than US$5m by 2025.

· Nutrien expects to treat approximately 150,000 hectares of soybeans in 2022, expanding to more than one million hectares by 2025.

· The Total Addressable Market for Saori in Brazil in 2022 is estimated at 40 million hectares of soybean fields.

· Saori-treated fields were healthier and more robust, with lower incidence of disease compared to untreated fields. 

· In PHC's own trials, the average yield increase was almost 10%.

 

Background

Plant Health Care has invested more than $25 million in its PREtec peptide technology platform ("Vaccines for Plants"). PREtec is a novel class of technology which stimulates the plant to defend itself. Derived from natural proteins, PREtec is an environmentally friendly approach to protecting crops and is compatible with mainstream agricultural practices. 

 

The Company plans major launches of PREtec products every year. Saori was the first product to be launched from the PREtec platform and is based on Plant Health Care's PHC279, a novel technology that makes soy plants healthier, improves resistance to multiple diseases and increases yield.

 

Ongoing field trials in Brazil with more than 200 soybean farmers in the 2021/22 season confirmed the benefits of Saori. Initial reports indicated Saori-treated fields were healthier and more robust, with lower incidence of disease compared to untreated fields. In PHC's own trials, the average yield increase was almost 10% and more than 90% of the Saori-treated fields showed a positive response.

 

With 40 million hectares (99 million acres) of soybeans planted in Brazil, this is a very large opportunity. Brazilian soybean farmers spent US$2.85 billion on disease control in the 2019/20 season. Saori offers a highly cost-effective tool to farmers to reduce spend on disease control and to increase yield.

 

 

Chris Richards, CEO of Plant Health Care said, ‟I am very pleased to see the positive response of Brazilian soybean growers to Nutrien's initial launch of Saori during the 2021/22 season. Building on that positive early momentum, we expect Saori-treated soybean seed to be planted on about 150,000 hectares next season, and many multiples of that amount over the next few years. Nutrien Ag Solutions is the very best partner for Saori, with multiple channels for making Saori available to Brazilian soybean growers. Saori is the first of many launches of products from the PREtec platform. We plan to launch PHC279 in the USA through our distributor, when regulatory permits have been obtained, expected in the second half of 2022. Thereafter, major PREtec product launches are planned each year. These launches underpin our confidence in Plant Health Care's growth projections for the coming years."

"Offering biological products is an important step to increasing the sustainability of Nutrien Ag Solution's product portfolio. As a company, we're looking for ways to make it easier for our customers to adopt sustainable practices on their lands, which is why we've invested a billion dollars into partnerships, research, and development into expanding our offerings of nature-based products," said Jeff Tarsi, Interim President of Global Retail, Nutrien Ag Solutions. "We're excited that we can partner with companies like Plant Health Care to bring more biological options for growers looking for alternatives to traditional synthetic products."

For further information, please contact:

 

Plant Health Care plc

Chris Richards, CEO

+1 919 926 1600

Cenkos Securities plc - Nomad & Broker

Neil McDonald / Pete Lynch

 +44 (0) 20 7391 8900

 

Vox Markets

Paul Cornelius / Kat Perez

+44 (0) 7866 384707

Nutrien Media Relations

Luciane Reis

Luciane.Reis@Nutrien.com

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile. Find out more at Vox Markets and the company website: www.planthealthcare.com

 

About Nutrien

Nutrien is the world's largest provider of crop inputs and services, playing a critical role in helping growers increase food production in a sustainable manner. We produce and distribute 27 million tonnes of potash, nitrogen and phosphate products world-wide. With this capability and our leading agriculture retail network, we are well positioned to supply the needs of our customers. We operate with a long-term view and are committed to working with our stakeholders as we address our economic, environmental and social priorities. The scale and diversity of our integrated portfolio provides a stable earnings base, multiple avenues for growth and the opportunity to return capital to shareholders. Nutrien Soluções Agrícolas is the retail business of Nutrien in Brazil, which has built a major presence through acquisitions and organic growth over the past decade.

 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRDGGDULGDDGDB
Date   Source Headline
1st Jun 200911:37 amRNSTotal Voting Rights
1st Jun 20097:00 amRNSEuropean Patent Granted for Harpin
28th May 20095:51 pmRNSAdditional Listing
28th May 20095:23 pmRNSSignificant Shareholding
28th May 20098:47 amRNSHolding(s) in Company
20th May 20099:30 amRNSAdditional Listing
19th May 20098:00 amRNSTest results
18th May 20093:47 pmRNSDirector/PDMR Shareholding
18th May 200910:44 amRNSAdditional Listing
13th May 20091:15 pmRNSDirector/PDMR Shareholding
12th May 200911:53 amRNSEGM Statement
30th Apr 200912:41 pmRNSDirector/PDMR Shareholding
24th Apr 200911:50 amRNSPlacing Announcement
16th Apr 20095:01 pmRNSAnnual Financial Report
15th Apr 20095:20 pmRNSAdditional Listing
2nd Apr 20095:47 pmRNSMonsanto Order
1st Apr 20093:40 pmRNSAdditional Listing
30th Mar 20097:00 amRNSDirector/PDMR Shareholding
24th Mar 200910:49 amRNSChange of Registered Office
24th Mar 20097:00 amRNSFinal Results
2nd Mar 200910:06 amRNSTotal Voting Rights
2nd Feb 200912:53 pmRNSTotal Voting Rights
2nd Feb 200911:01 amRNSBoard Appointment
28th Jan 20094:36 pmRNSPrice Monitoring Extension
28th Jan 20097:00 amRNSAdditional Listing
22nd Jan 20097:00 amRNSTrading Statement
15th Jan 20097:00 amRNSNew Appointments
5th Jan 20099:57 amRNSSignificant Shareholding
31st Dec 200811:19 amRNSTotal Voting Rights
19th Dec 20084:22 pmRNSHolding(s) in Company
18th Dec 20087:01 amRNSFurther re Myconate
18th Dec 20087:00 amRNSTermination of Agreement
16th Dec 20087:00 amRNSFinal Agreement with Monsanto
1st Dec 200810:02 amRNSTotal Voting Rights
26th Nov 20087:00 amRNSField Trials
18th Nov 200812:21 pmRNSAdditional Listing
31st Oct 20083:35 pmRNSTotal Voting Rights
30th Oct 20084:01 pmRNSBoard Appointment
20th Oct 200811:26 amRNSHolding(s) in Company
8th Oct 20081:05 pmRNSSignificant shareholding
2nd Oct 20087:52 amRNSField Trials
30th Sep 20088:00 amRNSTotal Voting Rights
25th Sep 20087:00 amRNSRe Scotts agreement
23rd Sep 20087:00 amRNSPreTect Field Trial Results
17th Sep 20087:00 amRNSAgreement with Bayer CropScience
15th Sep 20082:06 pmRNSPosting of Interim Results
9th Sep 20084:32 pmRNSDirector/PDMR Shareholding
8th Sep 20087:01 amRNSSupply Agreement
8th Sep 20087:00 amRNSInterim Results
1st Sep 200810:03 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.